Literature DB >> 7657794

Familial Hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3.

C A MacRae1, N Ghaisas, S Kass, S Donnelly, C T Basson, H C Watkins, R Anan, L H Thierfelder, K McGarry, E Rowland.   

Abstract

We have mapped a disease locus for Wolff-Parkinson-White syndrome (WPW) and familial hypertrophic cardiomyopathy (FHC) segregating in a large kindred to chromosome 7 band q3. Although WPW syndrome and FHC have been observed in members of the same family in prior studies, the relationship between these two diseases has remained enigmatic. A large family with 25 surviving individuals who are affected by one or both of these conditions was studied. The disease locus is closely linked to loci D7S688, D7S505, and D7S483 (maximum two point LOD score at D7S505 was 7.80 at theta = 0). While four different FHC loci have been described this is the first locus that can be mutated to cause both WPW and/or FHC.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7657794      PMCID: PMC185741          DOI: 10.1172/JCI118154

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  Wolff-Parkinson-White syndrome and familial cardiomegaly.

Authors:  R E WESTLAKE; W COHEN; W H WILLIS
Journal:  Am Heart J       Date:  1962-09       Impact factor: 4.749

2.  Syncope in hypertrophic cardiomyopathy. II. Coexistence of atrioventricular block and Wolff-Parkinson-White syndrome.

Authors:  G Z Khair; J S Soni; V S Bamrah
Journal:  Am Heart J       Date:  1985-11       Impact factor: 4.749

3.  Familial Wolff-Parkinson-White syndrome with cardiomyopathy.

Authors:  R A Massumi
Journal:  Am J Med       Date:  1967-12       Impact factor: 4.965

4.  Familial cardiomyopathy. A review of 11 families.

Authors:  I Kariv; B Kreisler; L Sherf; S Feldman; T Rosenthal
Journal:  Am J Cardiol       Date:  1971-12       Impact factor: 2.778

5.  Atrioventricular block and preexcitation in hypertrophic cardiomyopathy.

Authors:  P Touboul; G Kirkorian; G Atallah; P Cahen; C de Zuloaga; P Moleur
Journal:  Am J Cardiol       Date:  1984-03-15       Impact factor: 2.778

6.  A proposed autosomal dominant method of inheritance of the Wolff-Parkinson-White syndrome and supraventricular tachycardia.

Authors:  P C Gillette; D Freed; D G McNamara
Journal:  J Pediatr       Date:  1978-08       Impact factor: 4.406

7.  Anatomic substrate for preexcitation in idiopathic myocardial hypertrophy with fibroelastosis of the left ventricle.

Authors:  S Bharati; B Strasberg; M Bilitch; H Salibi; W Mandel; K M Rosen; M Lev
Journal:  Am J Cardiol       Date:  1981-07       Impact factor: 2.778

8.  Familial Wolff-Parkinson-White syndrome.

Authors:  B L Chia; F C Yew; S O Chay; A T Tan
Journal:  J Electrocardiol       Date:  1982-04       Impact factor: 1.438

9.  Pre-excitation syndrome and hypertrophic cardiomyopathy.

Authors:  A M Perosio; L D Suarez; A M Bunster; A Locreille; O A Apkarian; M A Vallazza; R Foye
Journal:  J Electrocardiol       Date:  1983-01       Impact factor: 1.438

10.  [Familial sudden death in preexcitation syndrome. Surgical interruption of the anomalous pathways in two brothers (author's transl)].

Authors:  G Critelli; J J Gallagher; W C Sealy; G G Lanza; M Condorelli
Journal:  G Ital Cardiol       Date:  1981
View more
  30 in total

1.  Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy.

Authors:  Michael Arad; D Woodrow Benson; Antonio R Perez-Atayde; William J McKenna; Elizabeth A Sparks; Ronald J Kanter; Kate McGarry; J G Seidman; Christine E Seidman
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

Review 2.  Clinical Spectrum of PRKAG2 Syndrome.

Authors:  Andrea Giuseppe Porto; Francesca Brun; Giovanni Maria Severini; Pasquale Losurdo; Enrico Fabris; Matthew R G Taylor; Luisa Mestroni; Gianfranco Sinagra
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-01

3.  Toxic adenoma of the thyroid gland and Wolff-Parkinson-White syndrome.

Authors:  M Naço; E Celiku; A Llukaçaj; J Shehaj; R Kameniku
Journal:  Hippokratia       Date:  2009-04       Impact factor: 0.471

4.  Molecular pathology of familial hypertrophic cardiomyopathy caused by mutations in the cardiac myosin binding protein C gene.

Authors:  B Yu; J A French; L Carrier; R W Jeremy; D R McTaggart; M R Nicholson; B Hambly; C Semsarian; D R Richmond; K Schwartz; R J Trent
Journal:  J Med Genet       Date:  1998-03       Impact factor: 6.318

5.  Genetic factors in familial hypertrophic cardiomyopathy: does molecular cardiology offer new perspectives?

Authors:  M Komajda
Journal:  Heart       Date:  1996-12       Impact factor: 5.994

6.  PRKAG2 mutations presenting in infancy.

Authors:  Rachel D Torok; Stephanie L Austin; Chanika Phornphutkul; Kathleen M Rotondo; Deeksha Bali; Gregory H Tatum; Stephanie B Wechsler; Anne F Buckley; Priya S Kishnani
Journal:  J Inherit Metab Dis       Date:  2017-08-11       Impact factor: 4.982

Review 7.  The genomics of cardiovascular disorders: therapeutic implications.

Authors:  P Ferrari; G Bianchi
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

Review 8.  Mendelian forms of structural cardiovascular disease.

Authors:  Calum A MacRae
Journal:  Curr Cardiol Rep       Date:  2013-10       Impact factor: 2.931

9.  Reversibility of PRKAG2 glycogen-storage cardiomyopathy and electrophysiological manifestations.

Authors:  Cordula M Wolf; Michael Arad; Ferhaan Ahmad; Atsushi Sanbe; Scott A Bernstein; Okan Toka; Tetsuo Konno; Gregory Morley; Jeffrey Robbins; J G Seidman; Christine E Seidman; Charles I Berul
Journal:  Circulation       Date:  2007-12-24       Impact factor: 29.690

10.  Mutation of the MYH7 gene in a child with hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome.

Authors:  Waldemar Bobkowski; Małgorzata Sobieszczańska; Anna Turska-Kmieć; Agnieszka Nowak; Józef Jagielski; Marzena Gonerska; Arleta Lebioda; Aldona Siwińska
Journal:  J Appl Genet       Date:  2007       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.